US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.240
  • +0.010+0.81%
Close Apr 19 16:00 ET
  • 1.220
  • -0.020-1.61%
Post 17:56 ET
87.95MMarket Cap-976P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
5.03%31.25M
126.62%17.57M
-51.19%9.28M
22.32%1.87M
73.98%2.53M
340.05%29.75M
416.52%7.75M
1,046.35%19.02M
-16.23%1.53M
-18.23%1.45M
Operating revenue
5.95%31.25M
131.55%17.57M
-51.12%9.28M
24.77%1.87M
77.65%2.53M
344.27%29.5M
415.84%7.59M
1,065.62%18.99M
-6.72%1.5M
-7.30%1.42M
Cost of revenue
51.18%18.08M
324.57%6.43M
-0.38%8.19M
49.06%1.59M
61.82%1.87M
153.77%11.96M
31.77%1.51M
648.23%8.22M
-15.44%1.07M
-3.91%1.16M
Gross profit
-25.99%13.17M
78.59%11.14M
-89.90%1.09M
-39.78%277K
121.14%659K
768.75%17.79M
1,672.44%6.24M
1,827.68%10.8M
-18.00%460K
-48.17%298K
Operating expense
25.78%129.48M
23.54%34.86M
4.09%30.67M
31.05%32.57M
53.77%31.38M
52.67%102.95M
34.08%28.22M
47.68%29.47M
80.53%24.85M
61.11%20.41M
Selling and administrative expenses
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
-2.78%5.81M
3.49%6.08M
26.35%6.1M
-General and administrative expense
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
-2.78%5.81M
3.49%6.08M
26.35%6.1M
Research and development costs
26.44%98.38M
26.45%26.65M
0.93%23.88M
34.59%25.28M
57.88%22.59M
77.60%77.81M
49.43%21.07M
69.26%23.66M
137.80%18.78M
82.52%14.31M
Operating profit
-36.59%-116.31M
-7.91%-23.72M
-58.42%-29.58M
-32.39%-32.29M
-52.77%-30.72M
-30.24%-85.15M
-6.21%-21.98M
3.72%-18.67M
-84.72%-24.39M
-66.31%-20.11M
Net non-operating interest income expense
Other net income (expense)
1,665.91%27.47M
486.49%21.86M
125.27%323K
-29.44%2.73M
94.08%2.56M
93.12%-1.75M
-167.93%-5.66M
27.01%-1.28M
177.94%3.86M
107.91%1.32M
Special income (charges)
503.34%18.96M
377.06%19.67M
9.41%-1.99M
-85.91%479K
-33.33%800K
80.69%-4.7M
-222.73%-7.1M
-144.44%-2.2M
170.83%3.4M
107.30%1.2M
-Less：Restructuring and merger&acquisition
-672.34%-26.9M
-470.42%-26.3M
-22.73%1.7M
55.88%-1.5M
33.33%-800K
-80.69%4.7M
222.73%7.1M
144.44%2.2M
-170.83%-3.4M
-107.30%-1.2M
-Less:Impairment of capital assets
--6.63M
----
----
----
----
--0
----
----
----
----
-Write off
--1.31M
--0
--293K
--1.02M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
188.83%8.51M
51.59%2.19M
151.19%2.32M
386.15%2.25M
1,389.83%1.76M
357.97%2.95M
1,522.47%1.44M
208.34%922K
398.06%462K
152.44%118K
Income before tax
-2.23%-88.85M
93.28%-1.86M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
Income tax
-367K
0
Net income
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
Net income continuous Operations
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
Minority interest income
Net income attributable to the parent company
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
34.66%-18.79M
Basic earnings per share
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
14.29%-0.3
8.82%-0.31
45.61%-0.31
Diluted earnings per share
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
14.29%-0.3
8.82%-0.31
45.61%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 5.03%31.25M126.62%17.57M-51.19%9.28M22.32%1.87M73.98%2.53M340.05%29.75M416.52%7.75M1,046.35%19.02M-16.23%1.53M-18.23%1.45M
Operating revenue 5.95%31.25M131.55%17.57M-51.12%9.28M24.77%1.87M77.65%2.53M344.27%29.5M415.84%7.59M1,065.62%18.99M-6.72%1.5M-7.30%1.42M
Cost of revenue 51.18%18.08M324.57%6.43M-0.38%8.19M49.06%1.59M61.82%1.87M153.77%11.96M31.77%1.51M648.23%8.22M-15.44%1.07M-3.91%1.16M
Gross profit -25.99%13.17M78.59%11.14M-89.90%1.09M-39.78%277K121.14%659K768.75%17.79M1,672.44%6.24M1,827.68%10.8M-18.00%460K-48.17%298K
Operating expense 25.78%129.48M23.54%34.86M4.09%30.67M31.05%32.57M53.77%31.38M52.67%102.95M34.08%28.22M47.68%29.47M80.53%24.85M61.11%20.41M
Selling and administrative expenses 23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M-2.78%5.81M3.49%6.08M26.35%6.1M
-General and administrative expense 23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M-2.78%5.81M3.49%6.08M26.35%6.1M
Research and development costs 26.44%98.38M26.45%26.65M0.93%23.88M34.59%25.28M57.88%22.59M77.60%77.81M49.43%21.07M69.26%23.66M137.80%18.78M82.52%14.31M
Operating profit -36.59%-116.31M-7.91%-23.72M-58.42%-29.58M-32.39%-32.29M-52.77%-30.72M-30.24%-85.15M-6.21%-21.98M3.72%-18.67M-84.72%-24.39M-66.31%-20.11M
Net non-operating interest income expense
Other net income (expense) 1,665.91%27.47M486.49%21.86M125.27%323K-29.44%2.73M94.08%2.56M93.12%-1.75M-167.93%-5.66M27.01%-1.28M177.94%3.86M107.91%1.32M
Special income (charges) 503.34%18.96M377.06%19.67M9.41%-1.99M-85.91%479K-33.33%800K80.69%-4.7M-222.73%-7.1M-144.44%-2.2M170.83%3.4M107.30%1.2M
-Less：Restructuring and merger&acquisition -672.34%-26.9M-470.42%-26.3M-22.73%1.7M55.88%-1.5M33.33%-800K-80.69%4.7M222.73%7.1M144.44%2.2M-170.83%-3.4M-107.30%-1.2M
-Less:Impairment of capital assets --6.63M------------------0----------------
-Write off --1.31M--0--293K--1.02M------0--0--0--0----
Other non- operating income (expenses) 188.83%8.51M51.59%2.19M151.19%2.32M386.15%2.25M1,389.83%1.76M357.97%2.95M1,522.47%1.44M208.34%922K398.06%462K152.44%118K
Income before tax -2.23%-88.85M93.28%-1.86M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M34.66%-18.79M
Income tax -367K0
Net income -1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M34.66%-18.79M
Net income continuous Operations -1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M34.66%-18.79M
Minority interest income
Net income attributable to the parent company -1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M34.66%-18.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M34.66%-18.79M
Basic earnings per share 4.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.4114.29%-0.38.82%-0.3145.61%-0.31
Diluted earnings per share 4.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.4114.29%-0.38.82%-0.3145.61%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg